USPTO serial 79015569
PEMITOPES
Reviewed by CopyMark Law Group
Reg. 3218186Status 404
- Filing date
- Status date
- Registration date
- Mar 13, 2007
- Examiner
- PERRY, KIMBERLY B
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PEMITOPES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science; chemical preparations for use in agriculture, namely, chemical preparations for the treatment of seeds; and chemical preparations for use in photography, namely, chemical developers, unprocessed artificial resins as raw materials in the form of powders, liquids or pastes, unprocessed plastics for industrial use, unprocessed plastics in all forms, manures, fire extinguishing compositions, tempering chemicals for use in metalworking or soldering, chemical substances for preserving foodstuffs, tanning agents for use in the manufacture of leather, adhesives for general industrial use | SECTION 71 - CANCELLED | — |
| 003 | Bleaching preparations for household use, general purpose cleaning, polishing, scouring and abrasive liquids and powders soaps, soaps, perfumery, essential oils for personal use and for use as ingredients in the manufacture of cosmetic preparations, cosmetics, hair lotions, dentifrices | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical anti-allergic preparations and substances, Pharmaceutical for the treatment of erectile dysfunction, Pharmaceutical preparations namely, anticoagulants, Pharmaceutical preparations namely, antidepressants, Pharmaceutical preparations namely, appetite suppressants, Pharmaceutical preparations for use in chemotherapy, Pharmaceutical preparation for the treatment of gout, Pharmaceutical preparations for the treatment of heart rhythm disorders, Pharmaceutical preparations for the treatment of stem cell mobilization, Pharmaceutical preparations for the treatment of infectious diseases, Pharmaceutical preparations acting on the central nervous system, Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, Pharmaceutical preparations for animal skincare, Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, Pharmaceutical preparations for ocular or intraocular surgery, Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, Pharmaceutical preparations for treating allergic rhinitis and asthma, Pharmaceutical preparations for treating diabetes, Pharmaceutical preparations for treating skin disorders, Pharmaceutical preparations for use in dermatology, Pharmaceutical preparations for wounds, Pharmaceutical preparations for use in urology, Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine, Pharmaceutical products and preparations against dry skin caused by pregnancy, Pharmaceutical products and preparations for chloasma, Pharmaceutical products and preparations for hydrating the skin during pregnancy, Pharmaceutical products and preparations for pregnancy blemishes, Pharmaceutical products and preparations for preventing skin blemishes during pregnancy, Pharmaceutical products and preparations to prevent stretch marks, Pharmaceutical products and preparations to prevent swelling in the legs, Pharmaceutical products for ophthalmological use, Pharmaceutical products for skin care for animals, Pharmaceutical products for the treatment of bone diseases, Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer, Pharmaceutical products for treating respiratory diseases and asthma, Pharmaceutical skin lotions, Pharmaceutical solutions used in dialysis, Pharmaceuticals for the treatment of erectile dysfunction, Pharmaceuticals, namely, antihelmintics, Pharmaceuticals, namely, inducers of erections, Pharmaceuticals, namely, lipid lowering agents, Pharmaceuticals, namely, psychotropics, Pharmaceuticals, namely, anti-infectives; and Veterinary preparations, namely, pain relief medication, veterinary preparations for the treatment of intestinal bacteria, Veterinary vaccine for horses, Veterinary vaccines; sanitary preparations for medical purposes; dietetic foods adapted for medical use, food for babies; medical plasters, dressings for wounds, burns, surgery; dental impression materials; disinfectants for hygienic purposes; preparations for destroying vermin; fungicides, herbicides | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services in the nature of research in the field of agrochemicals, pharmaceuticals and bio-chemistry and design services relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Polyphor AG
- Other trademarks owned by Polyphor AG
- Other trademarks owned by Polyphor AG
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named PEMITOPES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 20, 2013 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Oct 20, 2013 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Oct 18, 2013 | C71T | CANCELLED SECTION 71 | — |
| Oct 9, 2009 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Oct 9, 2009 | CANT | CANCELLATION TERMINATED NO. 999999 | — |
| Oct 9, 2009 | CAND | CANCELLATION DENIED NO. 999999 | — |
| May 4, 2009 | PETC | CANCELLATION INSTITUTED NO. 999999 | — |
| Jun 27, 2008 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 22, 2008 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 18, 2007 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 18, 2007 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 10, 2007 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 13, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 26, 2006 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 6, 2006 | NPUB | NOTICE OF PUBLICATION | — |
| Oct 31, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 13, 2006 | ALIE | ASSIGNED TO LIE | — |
| Oct 6, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 5, 2006 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Oct 5, 2006 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 5, 2006 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 19, 2006 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 19, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 6, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 31, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 31, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 13, 2006 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 23, 2006 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 23, 2006 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 22, 2006 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 21, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 20, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 24, 2005 | NWAP | NEW APPLICATION ENTERED | — |
| Oct 20, 2005 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |